+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07316270

Evaluating Safety and Effectiveness of Catheter Ablation versus Usual Care for Patients with Atrial Fibrillation and Intracranial Hemorrhage

Led by Beijing Anzhen Hospital · Updated on 2026-08-07

646

Participants Needed

7

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare catheter ablation with usual care in patients who have atrial fibrillation AF and a history of spontaneous intracranial hemorrhage. AF increases risks such as stroke, heart failure, and death. While oral anticoagulation can prevent clots, it raises bleeding risk. About 20-25% of patients with intracranial hemorrhage have AF, and restarting anticoagulation may help prevent stroke but also increase bleeding. The study investigates whether catheter ablation, specifically pulsed field ablation PFA, can provide better long-term benefits by maintaining normal heart rhythm and potentially reducing the need for long-term anticoagulation. Participants will be randomly assigned to either receive catheter ablation or usual care. Those in the catheter ablation group will undergo PFA followed by one month of low-dose direct oral anticoagulants such as rivaroxaban, dabigatran, or edoxaban. Patients with paroxysmal AF will receive bilateral pulmonary vein isolation, while those with persistent AF will receive a more extensive ablation strategy. The study will follow participants for at least two years to assess outcomes. During the trial, participants will be regularly monitored for events including death, stroke, and systemic embolism, which are combined as the primary outcome. Secondary measures include different types of stroke, bleeding events, cardiovascular death, quality of life, cognitive function, and disability scores. The study involves ongoing assessments over a 48-month period to evaluate long-term safety and effectiveness, aiming to find a safer treatment approach for AF patients with intracranial hemorrhage.

CONDITIONS

Brief Title

SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)

Research Team

L

Liu He

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here